The Impact of Natural Product Dietary Supplements on Patients with Gout: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Abstract

Natural product dietary supplements (NPDS) are frequently used for the treatment of gout, but reliable efficacy and safety data are generally lacking or not well organized to guide clinical decision making. This review aims to explore the impacts of NPDS for patients with gout. An electronic literature search was conducted to retrieve data published in English language from databases from inception to August 14, 2019. Randomized controlled trials (RCTs) that compared NPDS with or without placebo, diet modification, conventional pharmaceutics, or the other Chinese medicine treatment for gout patients were included. Two authors screened the articles, extracted the data, and assessed the risk of bias of each included trial independently. Meta-analysis was performed using Review Manager version 5.3.5. Results. Nine RCTS were enrolled in this review. The methodological quality of the nine RCTs was poor. The study results showed that in the majority of trials, NPDS demonstrated some degree of therapeutic efficacy for joint swelling, pain, and activity limitation. In contradistinction, serum uric acid (SUA) level (SMD −1.80, 95% CI: −4.45 to 0.86) (p>0.05) and CRP levels (N = 232; SMD, −0.26; 95% CI, −0.55 to 0.04) (p>0.05) did not improve significantly. The incidence of adverse events (AEs) was not lower in the participants treated with NPDS (N = 750; RR, 0.47; 95% CI, 0.20–1.11) (p>0.05). Conclusion. Current existing evidence is not sufficient to provide clinical guidance regarding the efficacy and safety of NPDS as a treatment for gout due to poor trial quality and lack of standardized evaluation criteria. Larger and more rigorously designed RCTs are needed in the future.

Therapeutic Pharmacological Properties of Citrullus Colocynthis Fruit Pulps Methanolic Crude Extract Against Potassium Oxonate-Induced Hyperuricemic Gout Rat Model

“…Gout, a MSU crystals metabolic disorder, is characterized by the high levels of SUA, the deposits of the MSU crystals into the synovial joints, tendons and the soft surrounding tissues, and acute inflammatory arthritis 32&33 . Moreover, edema, redness, acute inflammation, severe pain and stiffness of the affected joints and connective tissues are considered as the most common signs and symptoms of gout 34 . In this study, the principle strategy of gout and HUA treatment aimed to use traditional synthetic agent (Allo) and natural product (Cc) to examine their urate-lowering, anti-gout, and antioxidant properties against the hyperuricemic gout rat model.…”

Pathogenesis and Prevention of Avian Gout

“…The most distinctive phenomenon is the "tinea kidney", in which the kidney is covered with snowflake patterns formed by urate deposits. Gout is one of the most common mammalian and avian metabolic diseases, and is an arthritic form of hyperuricemia (Yang et al 2020). Due to the lack of uric acid oxidase and glutamine synthetase in poultry, it is difficult for ammonia to be converted into urea through the guanine cycle and it is difficult to be excreted.…”

Persistent Purine Metabolic Abnormality Induces the Aggravation of Visceral Inflammation and Intestinal Microbiota Dysbiosis in Magang Goose

“…Gout is one of the most common metabolic diseases in mammals and birds, which is a form of inflammatory arthritis in the setting of hyperuricemia ( 1 ). The incidence of gout is rising worldwide, and in 2018, the prevalence of gout was ~3% in humans, with a tendency for a disproportionately higher prevalence in the younger generation, because of improvements in living standards and changes in dietary habits ( 2 ).…”